Pharmagest Interactive SA
F:PHF
Pharmagest Interactive SA
Other Items
Pharmagest Interactive SA
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharmagest Interactive SA
F:PHF
|
Other Items
-€3.4m
|
CAGR 3-Years
45%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Cegedim SA
PAR:CGM
|
Other Items
-€21.4m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-71%
|
|
|
Equasens SA
PAR:EQS
|
Other Items
-€3.4m
|
CAGR 3-Years
45%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Median Technologies SA
PAR:ALMDT
|
Other Items
-€14k
|
CAGR 3-Years
2%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Pharmagest Interactive SA
Glance View
Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
See Also
What is Pharmagest Interactive SA's Other Items?
Other Items
-3.4m
EUR
Based on the financial report for Jun 30, 2025, Pharmagest Interactive SA's Other Items amounts to -3.4m EUR.
What is Pharmagest Interactive SA's Other Items growth rate?
Other Items CAGR 5Y
34%
Over the last year, the Other Items growth was 42%. The average annual Other Items growth rates for Pharmagest Interactive SA have been 45% over the past three years , 34% over the past five years .
